Skip to main content

Research Repository

Advanced Search

Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care

Jones, Matthew; Akyea, Ralph K.; Payne, Katherine; Humphries, Steve E.; Abdul-Hamid, Hasidah; Weng, Stephen; Qureshi, Nadeem


Assistant Professor in Health Economics

Katherine Payne

Steve E. Humphries

Hasidah Abdul-Hamid

Stephen Weng


Although familial hypercholesterolemia (FH) screening within primary care is considered cost-effective, which screening approach is cost-effective has not been established. This study determines the cost-effectiveness of six case-finding strategies for screening of electronic health records to identify index patients who have genetically confirmed monogenic FH in English primary care. A decision tree was constructed to represent pathways of care for each approach (FH Case Identification Tool (FAMCAT) versions 1 and 2, cholesterol screening, Dutch Lipid Clinic Network (DLCN), Simon Broome criteria, no active screening). Clinical effectiveness was measured as the number of monogenic FH cases identified. Healthcare costs for each algorithm were evaluated from an NHS England perspective over a 12 week time horizon. The primary outcome was the incremental cost per additional monogenic FH case identified (ICER). FAMCAT2 was found to dominate (cheaper and more effective) cholesterol and FAMCAT1 algorithms, and extendedly dominate DLCN. The ICER for FAMCAT2 vs. no active screening was 8111 GBP (95% CI: 4088 to 14,865), and for Simon Broome vs. FAMCAT2 was 74,059 GBP (95% CI: ?1,113,172 to 1,697,142). Simon Broome found the largest number of FH cases yet required 102 genetic tests to identify one FH patient. FAMCAT2 identified fewer, but only required 23 genetic tests.


Jones, M., Akyea, R. K., Payne, K., Humphries, S. E., Abdul-Hamid, H., Weng, S., & Qureshi, N. (2022). Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care. Journal of Personalized Medicine, 12(3), Article 330.

Journal Article Type Article
Acceptance Date Feb 18, 2022
Online Publication Date Feb 22, 2022
Publication Date Mar 1, 2022
Deposit Date Feb 28, 2022
Publicly Available Date Mar 1, 2022
Journal Journal of Personalized Medicine
Electronic ISSN 2075-4426
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 12
Issue 3
Article Number 330
Keywords economic evaluation; cost-effectiveness; genetics; electronic health records; familial hypercholesterolemia
Public URL
Publisher URL